Risk Assessment of Coronary Functional Reserve Under Rapid Changes in Physical Demand

Abstract

Coronary functional reserve (CFR) is a critical determinant of the heart's ability to adapt to varying metabolic demands, particularly during rapid changes in physical activity. In clinical practice, accurate risk assessment of CFR under dynamic conditions is essential for optimizing patient outcomes, especially among populations at increased risk of coronary artery disease (CAD). This review explores the epidemiology, underlying pathophysiology, risk factors, clinical manifestations, diagnostic approaches, and management strategies related to CFR assessment during acute physical stress. Furthermore, it discusses recent advances in non-invasive imaging and emerging therapies, integrating evidence-based guidelines and practical implications for healthcare professionals.

Introduction

Coronary functional reserve refers to the difference between resting and maximal coronary blood flow, reflecting the myocardium's ability to increase perfusion in response to increased workload. Rapid changes in physical demand, such as during exercise or acute stress, place significant strain on this reserve. Understanding the risk factors and clinical consequences associated with impaired CFR is pivotal in modern cardiology, as it directly impacts the diagnosis, prognosis, and management of patients with known or suspected coronary artery disease. This review synthesizes current scientific evidence and clinical guidelines to provide a comprehensive overview tailored to the needs of practicing clinicians.

Epidemiology / Disease Burden

Epidemiological studies indicate that impaired CFR is prevalent among individuals with established CAD, heart failure, diabetes mellitus, and other metabolic syndromes. The prevalence increases with age, presence of multiple cardiovascular risk factors, and in certain ethnic groups with higher baseline cardiovascular risk. Data from population-based cohorts, such as the Framingham Heart Study and large-scale registries, demonstrate that reductions in CFR are strongly associated with adverse cardiovascular outcomes, including myocardial infarction, sudden cardiac death, and heart failure. Rapid changes in physical demand, such as those experienced during strenuous exercise or acute emotional stress, can unmask subclinical impairment, highlighting the importance of risk stratification in at-risk populations.

Pathophysiology

The pathophysiological basis of CFR lies in the interplay between coronary artery patency, endothelial function, microvascular integrity, and myocardial metabolic demand. During rapid increases in physical activity, sympathetic activation leads to increased heart rate, contractility, and oxygen demand. Normally, coronary vessels dilate to augment blood flow; however, in the presence of atherosclerosis, endothelial dysfunction, or microvascular disease, this response is blunted. Impaired CFR results in inadequate myocardial perfusion relative to demand, predisposing to ischemia, arrhythmias, and contractile dysfunction. Mechanistic studies highlight the role of nitric oxide bioavailability, oxidative stress, vascular smooth muscle responsiveness, and structural remodeling in modulating CFR under stress conditions.

Risk Factors

Key risk factors for impaired CFR include advanced age, male sex, hypertension, diabetes mellitus, dyslipidemia, smoking, obesity, physical inactivity, and family history of premature CAD. Systemic inflammatory states, chronic kidney disease, and genetic predispositions also contribute to microvascular dysfunction. Acute triggers, such as emotional stress or sudden exertion, may precipitate ischemic events in individuals with marginal CFR. Recognizing these risk factors is essential for early identification and targeted intervention among high-risk cohorts.

Clinical Features

Patients with compromised CFR may present with exertional angina, dyspnea, palpitations, or fatigue, particularly during sudden increases in physical activity. In some cases, symptoms may be absent at rest but emerge under stress, underscoring the importance of provocative testing. Atypical or silent ischemia is common among diabetics and the elderly, complicating clinical recognition. Acute ischemic events, such as unstable angina or myocardial infarction, may occur in the context of severe CFR impairment when demand acutely exceeds supply.

Diagnosis

Assessment of CFR is achieved through both invasive and non-invasive modalities. Invasive coronary angiography with Doppler flow wire or thermodilution techniques remains the gold standard for quantifying absolute and relative CFR. Non-invasive approaches, such as positron emission tomography (PET), cardiac magnetic resonance imaging (CMR), and transthoracic Doppler echocardiography, have gained prominence for their safety and ability to assess global and regional CFR. Stress testing, including treadmill or pharmacologic protocols, is essential for unmasking dynamic impairments in CFR. Emerging technologies, such as computed tomography-derived fractional flow reserve (FFR-CT) and artificial intelligence-enhanced imaging, are enhancing diagnostic precision.

Treatment & Management

Management strategies aim to optimize myocardial perfusion and reduce cardiovascular risk. First-line therapy includes aggressive risk factor modification: antihypertensive therapy, statins, glycemic control, weight management, and smoking cessation. Pharmacologic agents such as beta-blockers, calcium channel blockers, and nitrates are employed to reduce myocardial oxygen demand and improve coronary flow. In select cases with significant epicardial stenosis, revascularization via percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is indicated. Comprehensive cardiac rehabilitation programs are crucial for improving exercise tolerance and CFR.

Recent Advances / Emerging Therapies

Recent advances in the assessment and management of CFR focus on non-invasive imaging, molecular diagnostics, and targeted therapies. PET and CMR allow for robust quantification of microvascular dysfunction, even in the absence of obstructive CAD. Pharmacologic innovations include agents targeting endothelial dysfunction, such as SGLT2 inhibitors, GLP-1 agonists, and novel vasodilators. Regenerative therapies aimed at restoring microvascular integrity and endothelial health are under investigation. The integration of machine learning algorithms into imaging platforms is refining risk stratification and personalized management strategies.

Guideline Recommendations

Contemporary clinical guidelines from leading societies, including the American College of Cardiology (ACC) and European Society of Cardiology (ESC), advocate for the use of CFR assessment in patients with intermediate-risk symptoms, unexplained dyspnea, or inconclusive non-invasive testing. Risk stratification should guide the intensity of medical therapy and the need for revascularization. Guidelines emphasize the importance of lifestyle interventions, optimal pharmacotherapy, and regular follow-up to monitor CFR and prevent adverse cardiovascular events.

Conclusion

Accurate risk assessment of coronary functional reserve during rapid changes in physical demand is essential for preventing ischemic events and optimizing patient outcomes. Advances in non-invasive diagnostics and evidence-based therapeutics are enhancing the clinician's ability to identify, stratify, and treat individuals at risk. Continued research into the mechanisms and management of CFR impairment will inform future guidelines and improve cardiovascular care, particularly as the burden of coronary artery disease continues to rise globally.